Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Cancer|November 26, 2010
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsAnne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2023
A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patientsAsbjørn Due, Tobias Berg, Maj-Britt Jensen, et al.
Plos One|October 10, 2014
A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor modelsAnja Bille Bohn, Thomas Wittenborn, Anne Sofie Brems-Eskildsen, et al.
Acta Oncologica (Stockholm, Sweden)|December 1, 2020
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancerAnne Sofie Brems-Eskildsen, Søren Linnet, Hella Danø, et al.
Breast Cancer Research and Treatment|July 11, 2025
A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trialAnne Sofie Brems-Eskildsen, Julia Kenholm, Annette Torbøl Brixen, et al.
Future Oncology (London, England)|June 20, 2019
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancerSven Tyge Langkjer, Julia Kenholm, Jeanette Dupont Jensen, et al.
Molecular & Cellular Proteomics : MCP|March 21, 2008
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysisKasper Thorsen, Karina D Sørensen, Anne Sofie Brems-Eskildsen, et al.
Pageof 1